1-3 of 3
Jin Won Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P02-03: Phase Ia/Ib dose-escalation study of ABL001 (CTX-009, bispecific antibody targeting DLL4 and VEGF-A) as a single agent in patients with advanced solid tumors

Jeeyun Lee, SeungTae Kim, JungYong Hong, YoungSuk Park, JoonOh Park, WonKi Kang, Keun-Wook Lee, Jin Won Kim, Ji-Won Kim, Se Hyun Kim, Eunsin Ha, Sangmi Lee, JongRan Kim, Weon-Kyoo You
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P02-03.
https://doi.org/10.1158/1535-7163.TARG-21-P02-03
Published: 01 December 2021
View article titled, Abstract P02-03: Phase Ia/Ib dose-escalation study of ABL001 (CTX-009, bispecific antibody targeting DLL4 and VEGF-A) as a single agent in patients with advanced solid tumors
Journal Articles

Abstract C074: Preclinical study of antitumor effect of alpelisib combined with paclitaxel in gastric caner

Ji-Won Kim, Kui-Jin Kim, Ji Hea Sung, Koung Jin Suh, Ji Yun Lee, Se Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Soo-Mee Bang, Jee Hyun Kim, Jong Seok Lee, Keun-Wook Lee
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): C074.
https://doi.org/10.1158/1535-7163.TARG-19-C074
Published: 01 December 2019
View article titled, Abstract C074: Preclinical study of antitumor effect of alpelisib combined with paclitaxel in gastric caner
Journal Articles

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

Ahrum Min, Seock-Ah Im, Hyemin Jang, Seongyeong Kim, Miso Lee, Debora Keunyoung Kim, Yaewon Yang, Hee-Jun Kim, Kyung-Hun Lee, Jin Won Kim, Tae-Yong Kim, Do-Youn Oh, Jeff Brown, Alan Lau, Mark J. O'Connor, Yung-Jue Bang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (4): 566–577.
https://doi.org/10.1158/1535-7163.MCT-16-0378
Published: 02 April 2017
View article titled, AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
Open the PDF for AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells in another window
Includes: Supplementary data